Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Outpatient (ex Primary Care)

 

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Dr Rajgopal Thirumalai, Vice President, Global Medical & Occupational Health, Unilever

Unilever runs a global health and prevention programme in over 90 countries for its 169,000  employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.

Interview: Charles Wang, Group CEO, Luye Medical Group

Formed as recently as 2015, Singapore-based Luye Medical Group has become one of the major contenders in health care services across China, Australia and SE Asia. It is part of the Luye Life Sciences Group which owns Luye Pharma Group, one of the largest pharmaceutical companies in China and separately listed on the Hong Kong Stock Exchange. Luye Medical Group acquired Healthe Care, the third largest Australian for-profit hospital operators in 2016. It has since expanded its business rapidly adding healthcare operations such as oncology (Singapore), inpatient, outpatient and community based health care services (Australia) and rehabilitation and maternity hospitals (China). The aim, says Wang, is mainly to provide a value-based healthcare experience to meet the needs of the middle class and patients with private insurance coverage across SE Asia, Australia and China. Here we talk to him about Luye Medical Group’s plans and how it views the Chinese market. Wang is a speaker at HBI 2018, the global health care service event in London from April 10 to 11.

Integrated care and value health set to soar in Europe

European politicians increasingly get the value of care which integrates social and acute or the holistic treatment of chronic diseases. They also want value healthcare models which reward operators for quality. Pilots are becoming larger and, in some cases, have been rolled out as long-term projects covering millions of people. There are plenty of opportunities for nimble private sector players. We look at what is happening across Europe.

Optimedis gets new investor

Integrated care operator Optimedis, which is now active in the UK and the Netherlands as well as Germany, is getting a new round of financing and has also linked up with big diagnostic groups. 

Nordic chain cracks America and looks to the world

A Nordic addiction clinic chain has cracked America, licensing its methodology to two North American groups and is now looking at international expansion in Far East Asia and the Middle East, including taking equity in partners. It claims that its outpatient approach achieves better results than inpatient rehab at a tenth of the cost and puts the size of the US addiction treatment market at $35bn.

Big Brazilian HMOs mull IPOs or sale

Several big Brazilian vertically integrated insurance/hospital groups are planning IPOs. Meanwhile, big US healthcare insurers and Chinese investors are sniffing around. 

Find Us